These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36278836)

  • 1.
    Chen Z; Xu J; Xing X; Xue C; Luo X; Gao S; Mao Z
    Ren Fail; 2022 Dec; 44(1):1791-1800. PubMed ID: 36278836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.
    Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
    Lin CJ; Wu V; Wu PC; Wu CJ
    PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of p-cresyl sulfate and indoxyl sulfate, but not inflammatory markers, increase in incident peritoneal dialysis patients in parallel with loss of residual renal function.
    Viaene L; Meijers BK; Bammens B; Vanrenterghem Y; Evenepoel P
    Perit Dial Int; 2014; 34(1):71-8. PubMed ID: 24179107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease.
    Glorieux G; Vanholder R; Van Biesen W; Pletinck A; Schepers E; Neirynck N; Speeckaert M; De Bacquer D; Verbeke F
    Nephrol Dial Transplant; 2021 May; 36(6):998-1005. PubMed ID: 33508125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shen-Shuai-Ning granule decreased serum concentrations of indoxyl sulphate in uremic patients undergoing peritoneal dialysis.
    Chen X; Gao S; Ruan M; Chen S; Xu J; Xing X; Pan X; Mei C; Mao Z
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29921575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High correlation between clearance of renal protein-bound uremic toxins (indoxyl sulfate and p-cresyl sulfate) and renal water-soluble toxins in peritoneal dialysis patients.
    Huang WH; Hung CC; Yang CW; Huang JY
    Ther Apher Dial; 2012 Aug; 16(4):361-7. PubMed ID: 22817125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cardiovascular autonomic function and decreased protein-bound uremic toxins in patients with end-stage renal disease after peritoneal dialysis.
    Cheng BC; Lai YR; Huang CC; Lu CH
    J Int Med Res; 2020 Jul; 48(7):300060520933797. PubMed ID: 32692275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-cresyl sulfate is a valuable predictor of clinical outcomes in pre-ESRD patients.
    Lin CJ; Pan CF; Chuang CK; Sun FJ; Wang DJ; Chen HH; Liu HL; Wu CJ
    Biomed Res Int; 2014; 2014():526932. PubMed ID: 24592393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of free indoxyl and p-cresyl sulfate are associated with mineral metabolism variables and cardiovascular risk in hemodialysis patients.
    Arcidiacono T; Macrina L; Premaschi S; Bologna A; Magni G; Foligno N; Avino M; Belloni C; Palmieri N; Conte F; Bisegna S; Simonini M; Slaviero G; Locatelli M; Vezzoli G
    J Nephrol; 2022 Jun; 35(5):1457-1465. PubMed ID: 35175580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p-Cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease.
    Wu IW; Hsu KH; Lee CC; Sun CY; Hsu HJ; Tsai CJ; Tzen CY; Wang YC; Lin CY; Wu MS
    Nephrol Dial Transplant; 2011 Mar; 26(3):938-47. PubMed ID: 20884620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.
    Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W
    Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients--a prospective cohort study.
    Wu IW; Hsu KH; Hsu HJ; Lee CC; Sun CY; Tsai CJ; Wu MS
    Nephrol Dial Transplant; 2012 Mar; 27(3):1169-75. PubMed ID: 21891772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
    Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Accumulation of Gut Microbiome-derived Indoxyl Sulfate and P-Cresyl Sulfate in Patients With End-stage Renal Disease.
    Lin X; Liang W; Li L; Xiong Q; He S; Zhao J; Guo X; Xiang S; Zhang P; Wang H; Ying C; Yao Y; Zuo X
    J Ren Nutr; 2022 Sep; 32(5):578-586. PubMed ID: 34736844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of bowel habits on gut-derived toxins in peritoneal dialysis patients.
    Pereira NBF; Ramos CI; de Andrade LS; Teixeira RR; Nakao LS; Rodrigues SD; de Lima JD; Dalboni MA; Cuppari L
    J Nephrol; 2020 Oct; 33(5):1049-1057. PubMed ID: 32737690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.
    Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X
    Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
    Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating
    Chang JF; Hsieh CY; Liou JC; Lu KC; Zheng CM; Wu MS; Chang SW; Wang TM; Wu CC
    Toxins (Basel); 2021 Jul; 13(7):. PubMed ID: 34357951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.
    Lin CJ; Pan CF; Liu HL; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ
    Atherosclerosis; 2012 Nov; 225(1):173-9. PubMed ID: 22981405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.